Identifying children with Cystic Fibrosis in population-scale routinely collected data in Wales: A Retrospective Review

Griffiths, R, Schluter, DK, Akbari, A, Cosgriff, R, Tucker, D and Taylor-Robinson, D ORCID: 0000-0002-5828-7724
(2020) Identifying children with Cystic Fibrosis in population-scale routinely collected data in Wales: A Retrospective Review. INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE (IJPDS), 5 (1). 1346-.

Access the full-text of this item by clicking on the Open Access link.
[img] Text
IJPDS_CFLinkagePaper.pdf - Published Version

Download (467kB) | Preview


<h4>Introduction</h4>The challenges in identifying a cohort of people with a rare condition can be addressed by routinely collected, population-scale electronic health record (EHR) data, which provide large volumes of data at a national level. This paper describes the challenges of accurately identifying a cohort of children with Cystic Fibrosis (CF) using EHR and their validation against the UK CF Registry.<h4>Objectives</h4>To establish a proof of principle and provide insight into the merits of linked data in CF research; to identify the benefits of access to multiple data sources, in particular the UK CF Registry data, and to demonstrate the opportunity it represents as a resource for future CF research.<h4>Methods</h4>Three EHR data sources were used to identify children with CF born in Wales between 1<sup>st</sup> January 1998 and 31<sup>st</sup> August 2015 within the Secure Anonymised Information Linkage (SAIL) Databank. The UK CF Registry was later acquired by SAIL and linked to the EHR cohort to validate the cases and explore the reasons for misclassifications.<h4>Results</h4>We identified 352 children with CF in the three EHR data sources. This was greater than expected based on historical incidence rates in Wales. Subsequent validation using the UK CF Registry found that 257 (73%) of these were true cases. Approximately 98.7% (156/158) of individuals identified as CF cases in all three EHR data sources were confirmed as true cases; but this was only the case for 19.8% (20/101) of all those identified in just a single data source.<h4>Conclusion</h4>Identifying health conditions in EHR data can be challenging, so data quality assurance and validation is important or the merit of the research is undermined. This retrospective review identifies some of the challenges in identifying CF cases and demonstrates the benefits of linking cases across multiple data sources to improve quality.

Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 12 Aug 2020 08:32
Last Modified: 18 Jan 2023 23:37
DOI: 10.23889/ijpds.v5i1.1346
Open Access URL:
Related URLs: